Background: Medical and surgical
methods are available for abortions in both the first and second trimester.
Aim: To review the evidence base and current recommendations for available methods
of abortions in first and second trimesters. Methods: Extensive literature
search and review of available guidelinesweredone. Results: In the first trimester,
medical methods are recommended below 7 weeks gestation while vacuum aspiration
is an appropriate method between 7 to 12 weeks gestation. In the second
trimester, the three methods of abortion available are dilatation and
evacuation, intrauterine instillation of abortifacients and administration of
systemic abortifacients. Conclusion: The choice of techniques depends on many
factors including uterine volume, operator experience, patient preference,
medical history and indication for abortion.
References
[1]
Sedgh, G., Singh, S., Shah, I.H., et al. (2012) Induced Abortion: Incidence and Trends Worldwide from 1995 to 2008. The Lancet, 379, 625-632. http://dx.doi.org/10.1016/S0140-6736(11)61786-8
[2]
Singh, K. and Fong, Y.F. (2000) Preparation of the Cervix for Surgical Termination of Pregnancy in the First Trimester. Human Reproduction Update, 6, 442-448. http://dx.doi.org/10.1093/humupd/6.5.442
[3]
Royal College of Obstetricians and Gynaecologists (2011) The Care of Women Requesting Induced Abortion. Evidence-Based Clinical Guideline Number 7, RCOG, London.
[4]
American College of Obstetricians and Gynecologists (2014) Practice Bulletin No. 143: Medical Management of First-Trimester Abortion. Obstetrics & Gynecology, 123, 676-692.
http://dx.doi.org/10.1097/01.AOG.0000444454.67279.7d
[5]
Swahn, M.L. and Bygdeman, M. (1988) The Effect of the Antiprogestin RU 486 on Uterine Contractility and Sensitivity to Prostaglandin and Oxytocin. British Journal of Obstetrics and Gynaecology, 95, 126-134.
http://dx.doi.org/10.1111/j.1471-0528.1988.tb06840.x
[6]
El-Refaey, H., Rajasekar, D., Abdalla, M., et al. (1995) Induction of Abortion with Mifepristone (RU 486) and Oral or Vaginal Misoprostol. The New England Journal of Medicine, 332, 983-987.
http://dx.doi.org/10.1056/NEJM199504133321502
[7]
Spitz, I.M., Bardin, C.W., Benton, L. and Robbins, A. (1998) Early Pregnancy Termination with Mifepristone and Misoprostol in the United States. The New England Journal of Medicine, 338, 1241-1247.
http://dx.doi.org/10.1056/NEJM199804303381801
[8]
Kulier, R., Kapp, N., Gülmezoglu, A.M., Hofmeyr, G.J., Cheng, L. and Campana, A. (2011) Medical Methods for First Trimester Abortion (Review). Cochrane Database of Systematic Reviews, 11, Article ID: CD002855.
[9]
Schaff, E.A. (2010) Mifepristone: Ten Years Later. Contraception, 81, 1-7.
http://dx.doi.org/10.1016/j.contraception.2009.08.004
[10]
Creinin, M.D., Fox, M.C., Teal, S., Chen, A., Schaff, E.A. and Meyn, L.A. (2004) MOD Study Trial Group. A Randomized Comparison of Misoprostol 6 to 8 Hours versus 24 Hours after Mifepristone for Abortion. Obstetrics & Gynecology, 103, 851-859. http://dx.doi.org/10.1097/01.AOG.0000124271.23499.84
[11]
Singh, K., Fong, Y.F. and Dong, F. (2003) A Viable Alternative to Surgical Vacuum Aspiration: Repeated Doses of Intravaginal Misoprostol over 9 Hours for Medical Termination of Pregnancies up to Eight Weeks. BJOG: An International Journal of Obstetrics & Gynaecology, 110, 175-180. http://dx.doi.org/10.1046/j.1471-0528.2003.02225.x
[12]
Jain, J.K., Dutton, C., Harwood, B., Meckstroth, K.R. and Mishell Jr., D.R. (2002) A Prospective Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Mifepristone and Vaginal Misoprostol to Vaginal Misoprostol Alone for Elective Termination of Early Pregnancy. Human Reproduction, 17, 1477-1482.
http://dx.doi.org/10.1093/humrep/17.6.1477
[13]
Say, L., Kulier, R., Gülmezoglu, M. and Campana, A. (2005) Medical versus Surgical Methods for First Trimester Termination of Pregnancy. Cochrane Database of Systematic Reviews, Published Online.
[14]
Singh, K. and Fong, Y.F. (2000) Preparation of the Cervix for Surgical Termination of Pregnancy in the First Trimester. Human Reproduction Update, 6, 442-448. http://dx.doi.org/10.1093/humupd/6.5.442
[15]
Dey, M. (2013) Oral Misoprostol Is an Effective and Acceptable Alternative to Vaginal Administration for Cervical Priming before First Trimester Pregnancy Termination. Medical Journal Armed Forces India, 69, 27-30.
http://dx.doi.org/10.1016/j.mjafi.2012.07.014
[16]
Singh, K., Fong, Y.F., Prasad, R.N. and Dong, F. (1999) Evacuation Interval after Vaginal Misoprostol for Preabortion Cervical Priming: A Randomized Trial. Obstetrics & Gynecology, 94, 431-434.
[17]
Fong, Y.F., Singh, K. and Prasad, R.N. (1998) A Comparative Study Using Two Dose Regimens (200 Microg or 400 Microg) of Vaginal Misoprostol for Pre-Operative Cervical Dilatation in First Trimester Nulliparae. BJOG: An International Journal of Obstetrics & Gynaecology, 105, 413-417. http://dx.doi.org/10.1111/j.1471-0528.1998.tb10126.x
[18]
Singh, K., Fong, Y.F., Prasad, R.N. and Dong, F. (1999) Vaginal Misoprostol for Pre-Abortion Cervical Priming: Is There an Optimal Evacuation Time Interval? BJOG: An International Journal of Obstetrics & Gynaecology, 106, 266-269. http://dx.doi.org/10.1111/j.1471-0528.1999.tb08241.x
[19]
Singh, K., Fong, Y.F., Prasad, R.N. and Dong, F. (1998) Randomized Trial to Determine Optimal Dose of Vaginal Misoprostol for Preabortion Cervical Priming. Obstetrics & Gynecology, 92, 795-798.
http://dx.doi.org/10.1016/S0029-7844(98)00281-6
[20]
Fong, Y.F., Singh, K. and Prasad, R.N. (1999) Severe Hyperthermia Following Use of Vaginal Misoprostol for PreOperative Cervical Priming. International Journal of Gynecology and Obstetrics, 64, 73-74.
http://dx.doi.org/10.1016/S0020-7292(98)00151-9
[21]
Wen, J., Cai, Q.Y., Deng, F. and Li, Y.P. (2008) Manual versus Electric Vacuum Aspiration for First-Trimester Abortion: A Systematic Review. BJOG: An International Journal of Obstetrics & Gynaecology, 115, 5-13.
http://dx.doi.org/10.1111/j.1471-0528.2007.01572.x
[22]
Verkuyl, D.A. and Crowther, C.A. (1993) Suction v. Conventional Curettage in Incomplete Abortion. A Randomised Controlled Trial. South African Medical Journal, 83, 13-15.
[23]
Ngo, T.D., Park, M.H. and Free, C. (2013) Safety and Effectiveness of Termination Services Performed by Doctors versus Midlevel Providers: A Systematic Review and Analysis. International Journal of Women’s Health, 5, 9-17.
http://dx.doi.org/10.2147/IJWH.S39627
[24]
Stubblefield, P.G., Carr-Ellis, S. and Borgatta, L. (2004) Methods for Induced Abortion. Obstetrics & Gynecology, 104, 174-185. http://dx.doi.org/10.1097/01.AOG.0000130842.21897.53
[25]
Kafrissen, M.E., Schulz, K.F., Grimes, D.A. and Cates Jr., W. (1984) Midtrimester Abortion. Intra-Amniotic Instillation of Hyperosmolar Urea and Prostaglandin F2α v Dilatation and Evacuation. JAMA, 251, 916-919.
http://dx.doi.org/10.1001/jama.1984.03340310030014
[26]
American College of Obstetricians and Gynecologists (2013) Practice Bulletin No. 135: Second-Trimester Abortion. Obstetrics & Gynecology, 121, 1394-1406. http://dx.doi.org/10.1097/01.AOG.0000431056.79334.cc
[27]
Kapp, N., Borgatta, L., Stubblefield, P., Vragovic, O. and Moreno, N. (2007) Mifepristone in Second-Trimester Medical Abortion: A Randomized Controlled Trial. Obstetrics & Gynecology, 110, 1304-1310.
http://dx.doi.org/10.1097/01.AOG.0000289577.32274.a5
[28]
Ashok, P.W., Templeton, A., Wagaarachchi, P.T. and Flett, G.M. (2004) Midtrimester Medical Termination of Pregnancy: A Review of 1002 Consecutive Cases. Contraception, 69, 51-58.
http://dx.doi.org/10.1016/j.contraception.2003.09.006
[29]
Wong, K.S., Ngai, C.S., Yeo, E.L., Tang, L.C.H. and Ho, P.C. (2000) A Comparison of Two Regimens of Intravaginal Misoprostol for Termination of Second Trimester Pregnancy: A Randomized Comparative Trial. Human Reproduction, 15, 709-712. http://dx.doi.org/10.1093/humrep/15.3.709
[30]
Dickinson, J.E. and Evans, S.F. (2003) A Comparison of Oral Misoprostol with Vaginal Misoprostol Administration in Second-Trimester Pregnancy Termination for Fetal Abnormality. Obstetrics & Gynecology, 101, 1294-1299.
http://dx.doi.org/10.1016/S0029-7844(03)00357-0
[31]
Su, L.L., Biswas, A., Choolani, M., Kalaichelvan, V. and Singh, K. (2005) A Prospective, Randomized Comparison of Vaginal Misoprostol versus Intra-Amniotic Prostaglandins for Midtrimester Termination of Pregnancy. American Journal of Obstetrics & Gynecology, 193, 1410-1414. http://dx.doi.org/10.1016/j.ajog.2005.02.082
[32]
Peterson, W.F., Berry, F.N., Grace, M.R. and Gulbranson, C.L. (1983) Second-Trimester Abortion by Dilatation and Evacuation: An Analysis of 11,747 Cases. Obstetrics & Gynecology, 62, 185-190.
[33]
Embrey, M.P. and Hillier, K. (1971) Therapeutic Abortion by Intrauterine Instillation of Prostaglandins. British Medical Journal, 1, 588-590. http://dx.doi.org/10.1136/bmj.1.5749.588
